These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 32606678)
1. Targeted Nanobubbles Carrying Indocyanine Green for Ultrasound, Photoacoustic and Fluorescence Imaging of Prostate Cancer. Wang Y; Lan M; Shen D; Fang K; Zhu L; Liu Y; Hao L; Li P Int J Nanomedicine; 2020; 15():4289-4309. PubMed ID: 32606678 [TBL] [Abstract][Full Text] [Related]
2. Multifunctional nanobubbles carrying indocyanine green and paclitaxel for molecular imaging and the treatment of prostate cancer. Lan M; Zhu L; Wang Y; Shen D; Fang K; Liu Y; Peng Y; Qiao B; Guo Y J Nanobiotechnology; 2020 Sep; 18(1):121. PubMed ID: 32883330 [TBL] [Abstract][Full Text] [Related]
3. Indocyanine Green-Loaded Nanobubbles Targeting Carbonic Anhydrase IX for Multimodal Imaging of Renal Cell Carcinoma. Zhong C; Chen J; Ling Y; Liu D; Xu J; Wang L; Ge C; Jiang Q Int J Nanomedicine; 2023; 18():2757-2776. PubMed ID: 37250472 [TBL] [Abstract][Full Text] [Related]
4. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer. Ding Y; Cao Q; Qian S; Chen X; Xu Y; Chen J; Shen H J Ultrasound Med; 2020 Apr; 39(4):761-773. PubMed ID: 31702068 [TBL] [Abstract][Full Text] [Related]
5. Nanobody-loaded nanobubbles targeting the G250 antigen with ultrasound/photoacoustic/fluorescence multimodal imaging capabilities for specifically enhanced imaging of RCC. Chen J; Li J; Zhong C; Ling Y; Liu D; Li X; Xu J; Liu Q; Guo Y; Wang L Nanoscale; 2023 Dec; 16(1):343-359. PubMed ID: 38062769 [TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide- Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles. Fan X; Guo Y; Wang L; Xiong X; Zhu L; Fang K Int J Nanomedicine; 2016; 11():3939-50. PubMed ID: 27574424 [TBL] [Abstract][Full Text] [Related]
8. Efficacy evaluation and mechanism study on inhibition of breast cancer cell growth by multimodal targeted nanobubbles carrying AMD070 and ICG. Shen D; Zhu L; Liu Y; Peng Y; Lan M; Fang K; Guo Y Nanotechnology; 2020 Mar; 31(24):245102. PubMed ID: 32155591 [TBL] [Abstract][Full Text] [Related]
9. Construction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer. Wang L; Li L; Guo Y; Tong H; Fan X; Ding J; Huang H Prostate; 2013 Aug; 73(11):1147-58. PubMed ID: 23532872 [TBL] [Abstract][Full Text] [Related]
10. Magnetic polymeric nanobubbles with optimized core size for MRI/ultrasound bimodal molecular imaging of prostate cancer. Zhu Y; Sun Y; Liu W; Guan W; Liu H; Duan Y; Chen Y Nanomedicine (Lond); 2020 Dec; 15(30):2901-2916. PubMed ID: 33300812 [No Abstract] [Full Text] [Related]
11. Preparation Of Nanobubbles Modified With A Small-Molecule CXCR4 Antagonist For Targeted Drug Delivery To Tumors And Enhanced Ultrasound Molecular Imaging. Peng Y; Zhu L; Wang L; Liu Y; Fang K; Lan M; Shen D; Liu D; Yu Z; Guo Y Int J Nanomedicine; 2019; 14():9139-9157. PubMed ID: 32063704 [TBL] [Abstract][Full Text] [Related]
12. Ultrasonic Nanobubbles Carrying Anti-PSMA Nanobody: Construction and Application in Prostate Cancer-Targeted Imaging. Fan X; Wang L; Guo Y; Tu Z; Li L; Tong H; Xu Y; Li R; Fang K PLoS One; 2015; 10(6):e0127419. PubMed ID: 26111008 [TBL] [Abstract][Full Text] [Related]
13. Quantification of extravasation and binding of PSMA-targeted nanobubbles by modelling the second-wave phenomenon. Chen C; Perera R; Mischi M; Kolios M; Exner A; Turco S Mol Imaging Biol; 2024 Apr; 26(2):253-263. PubMed ID: 38151581 [TBL] [Abstract][Full Text] [Related]
14. Photoacoustic signal enhancement in dual-contrast gastrin-releasing peptide receptor-targeted nanobubbles. Zhao S; Lee L; Zhao Y; Liang NC; Chen YS Front Bioeng Biotechnol; 2023; 11():1102651. PubMed ID: 36733960 [TBL] [Abstract][Full Text] [Related]
15. Construction of Nucleolin-Targeted Lipid Nanobubbles and Contrast-Enhanced Ultrasound Molecular Imaging in Triple-Negative Breast Cancer. Fang K; Wang L; Huang H; Lan M; Shen D; Dong S; Guo Y Pharm Res; 2020 Jul; 37(7):145. PubMed ID: 32666304 [TBL] [Abstract][Full Text] [Related]
16. In vivo photoacoustic molecular imaging of breast carcinoma with folate receptor-targeted indocyanine green nanoprobes. Wang H; Liu C; Gong X; Hu D; Lin R; Sheng Z; Zheng C; Yan M; Chen J; Cai L; Song L Nanoscale; 2014 Nov; 6(23):14270-9. PubMed ID: 25321626 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic modeling of PSMA-targeted nanobubbles for quantification of extravasation and binding in mice models of prostate cancer. Chen C; Perera R; Kolios MC; Wijkstra H; Mischi M; Exner AA; Turco S Med Phys; 2022 Oct; 49(10):6547-6559. PubMed ID: 36049109 [TBL] [Abstract][Full Text] [Related]
18. Real time ultrasound molecular imaging of prostate cancer with PSMA-targeted nanobubbles. Perera RH; de Leon A; Wang X; Wang Y; Ramamurthy G; Peiris P; Abenojar E; Basilion JP; Exner AA Nanomedicine; 2020 Aug; 28():102213. PubMed ID: 32348874 [TBL] [Abstract][Full Text] [Related]
19. Prostate-specific membrane antigen-targeted photoacoustic imaging of prostate cancer in vivo. Zhang HK; Chen Y; Kang J; Lisok A; Minn I; Pomper MG; Boctor EM J Biophotonics; 2018 Sep; 11(9):e201800021. PubMed ID: 29653029 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy. Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]